Cisplatin is a platinum-based anticancer agent recognised for its remarkable efficacy; yet, its therapeutic use is limited by nephrotoxicity. Cisplatin-induced kidney injury is closely linked to tubular damage, oxidative stress, reduced antioxidant defense, altered nitric oxide bioavailability, iron buildup, lipid peroxidation, inflammation, vascular congestion, and histopathological damage. Pomegranate peel extract (PPE) contains punicalagin, gallic acid, ellagic acid, tannins, and flavonoids, which may have antioxidant and tissue-protective benefits. This research objective was to assess the reno-protective effects of pomegranate peel extract toward nephrotoxicity induced by cisplatin in Wistar rats. Thirty-six adult male rats were randomly divided into six experimental groups (n = 6/group): Control, PPE alone, Cisplatin, Cisplatin + low PPE, Cisplatin + high PPE, and Cisplatin + NAC. Pomegranate peel extract was administered orally at a dosage of 100 mg/kg in the low-dose group while the dose was 200 mg/kg in the PPE-only and high-dose groups. Nephrotoxicity induction was done using 8 mg/kg dose injection of cisplatin intraperitoneally on day 7, whereas N-acetylcysteine was used as a reference antioxidant at a dose of 250 mg/kg/day orally. Serum and tissue samples were collected on day 10 for biochemical and histopathological analysis. Rats in the control group had normal renal function, oxidative balance and minimal histological injury, with creatinine of 0.55 ± 0.07 mg/dL, BUN of 20.4 ± 2.8 mg/dL and low injury scores. Rats receiving PPE only remained similar to controls with preserved renal biomarkers and tissue architecture. Cisplatin caused marked nephrotoxicity as evidenced by increased serum creatinine (2.21 ± 0.31 mg/dL), BUN (78.6 ± 8.9 mg/dL), MDA (6.56 ± 0.61 nmol/mg) and histopathological injury. Cisplatin + low dose PPE partially improved renal function, oxidative stress and histological scores but values were abnormal compared to control. Cisplatin + high dose PPE gave stronger protection, lowering creatinine to 0.91 ± 0.12 mg/dL, BUN to 33.5 ± 4.8 mg/dL, MDA to 3.02 ± 0.34 nmol/mg, and significantly reducing tissue injury. Cisplatin + NAC had similar improvement, creatinine 0.84 +/- 0.11 mg/dL and BUN 30.8 +/- 4.4 mg/dL. Pomegranate peel extract attenuated cisplatin-induced renal dysfunction, oxidative stress, endothelial biochemical disturbance, and renal tissue injury. These effects may be related to polyphenol-mediated antioxidant, anti-inflammatory, membrane-stabilizing, and cytoprotective actions.